Potency and specificity of a growth hormone-releasing factor in a primate and in vitro

O. F X Almeida, H. M. Schulte, R. S. Rittmaster, G. P. Chrousos, Donald (Lynn) Loriaux, G. R. Merriam

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The potency and specificity of the 44-amino acid human pancreatic tumor GRF were tested in six adult female rhesus monkeys and in a perifusion system containing a suspension of rat pituicytes. In vivo, plasma GH levels were elevated in a dose-dependent fashion, with an ED50 of approximately 5 µg/kg, a value of the same order of magnitude as other hypothalamic releasing hormones. The magnitude of the GH response after GRF treatment was similar to that observed during insulininduced hypoglycemia, with peak plasma GH concentrations occurring 5–15 min after GRF administration. High doses of GRF slightly stimulated PRL release, but had no effect on arterial blood pressure, heart rate, or plasma cortisol or glucose concentrations. In vitro, GRF released GH in a dose-dependent manner, but no PRL was released even at the highest GRF concentrations employed (100 nM). It thus appears that stimulation of PRL in vivo may be an indirect effect of GRF. Alternatively, there may be species differences in responsiveness to GRF.

Original languageEnglish (US)
Pages (from-to)309-312
Number of pages4
JournalJournal of Clinical Endocrinology and Metabolism
Volume58
Issue number2
DOIs
StatePublished - 1984
Externally publishedYes

Fingerprint

Growth Hormone-Releasing Hormone
Primates
Plasmas
Pituitary Hormone-Releasing Hormones
Blood pressure
Macaca mulatta
Hypoglycemia
Hydrocortisone
Rats
Tumors
Suspensions
Arterial Pressure
Heart Rate
Amino Acids
Glucose
In Vitro Techniques
Neoplasms

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Potency and specificity of a growth hormone-releasing factor in a primate and in vitro. / Almeida, O. F X; Schulte, H. M.; Rittmaster, R. S.; Chrousos, G. P.; Loriaux, Donald (Lynn); Merriam, G. R.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 58, No. 2, 1984, p. 309-312.

Research output: Contribution to journalArticle

Almeida, O. F X ; Schulte, H. M. ; Rittmaster, R. S. ; Chrousos, G. P. ; Loriaux, Donald (Lynn) ; Merriam, G. R. / Potency and specificity of a growth hormone-releasing factor in a primate and in vitro. In: Journal of Clinical Endocrinology and Metabolism. 1984 ; Vol. 58, No. 2. pp. 309-312.
@article{fb161d9f36df45ddb975623e9f8670ca,
title = "Potency and specificity of a growth hormone-releasing factor in a primate and in vitro",
abstract = "The potency and specificity of the 44-amino acid human pancreatic tumor GRF were tested in six adult female rhesus monkeys and in a perifusion system containing a suspension of rat pituicytes. In vivo, plasma GH levels were elevated in a dose-dependent fashion, with an ED50 of approximately 5 µg/kg, a value of the same order of magnitude as other hypothalamic releasing hormones. The magnitude of the GH response after GRF treatment was similar to that observed during insulininduced hypoglycemia, with peak plasma GH concentrations occurring 5–15 min after GRF administration. High doses of GRF slightly stimulated PRL release, but had no effect on arterial blood pressure, heart rate, or plasma cortisol or glucose concentrations. In vitro, GRF released GH in a dose-dependent manner, but no PRL was released even at the highest GRF concentrations employed (100 nM). It thus appears that stimulation of PRL in vivo may be an indirect effect of GRF. Alternatively, there may be species differences in responsiveness to GRF.",
author = "Almeida, {O. F X} and Schulte, {H. M.} and Rittmaster, {R. S.} and Chrousos, {G. P.} and Loriaux, {Donald (Lynn)} and Merriam, {G. R.}",
year = "1984",
doi = "10.1210/jcem-58-2-309",
language = "English (US)",
volume = "58",
pages = "309--312",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Potency and specificity of a growth hormone-releasing factor in a primate and in vitro

AU - Almeida, O. F X

AU - Schulte, H. M.

AU - Rittmaster, R. S.

AU - Chrousos, G. P.

AU - Loriaux, Donald (Lynn)

AU - Merriam, G. R.

PY - 1984

Y1 - 1984

N2 - The potency and specificity of the 44-amino acid human pancreatic tumor GRF were tested in six adult female rhesus monkeys and in a perifusion system containing a suspension of rat pituicytes. In vivo, plasma GH levels were elevated in a dose-dependent fashion, with an ED50 of approximately 5 µg/kg, a value of the same order of magnitude as other hypothalamic releasing hormones. The magnitude of the GH response after GRF treatment was similar to that observed during insulininduced hypoglycemia, with peak plasma GH concentrations occurring 5–15 min after GRF administration. High doses of GRF slightly stimulated PRL release, but had no effect on arterial blood pressure, heart rate, or plasma cortisol or glucose concentrations. In vitro, GRF released GH in a dose-dependent manner, but no PRL was released even at the highest GRF concentrations employed (100 nM). It thus appears that stimulation of PRL in vivo may be an indirect effect of GRF. Alternatively, there may be species differences in responsiveness to GRF.

AB - The potency and specificity of the 44-amino acid human pancreatic tumor GRF were tested in six adult female rhesus monkeys and in a perifusion system containing a suspension of rat pituicytes. In vivo, plasma GH levels were elevated in a dose-dependent fashion, with an ED50 of approximately 5 µg/kg, a value of the same order of magnitude as other hypothalamic releasing hormones. The magnitude of the GH response after GRF treatment was similar to that observed during insulininduced hypoglycemia, with peak plasma GH concentrations occurring 5–15 min after GRF administration. High doses of GRF slightly stimulated PRL release, but had no effect on arterial blood pressure, heart rate, or plasma cortisol or glucose concentrations. In vitro, GRF released GH in a dose-dependent manner, but no PRL was released even at the highest GRF concentrations employed (100 nM). It thus appears that stimulation of PRL in vivo may be an indirect effect of GRF. Alternatively, there may be species differences in responsiveness to GRF.

UR - http://www.scopus.com/inward/record.url?scp=0021342473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021342473&partnerID=8YFLogxK

U2 - 10.1210/jcem-58-2-309

DO - 10.1210/jcem-58-2-309

M3 - Article

C2 - 6420435

AN - SCOPUS:0021342473

VL - 58

SP - 309

EP - 312

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 2

ER -